Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS)
about
Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosisScreening of Drugs Inhibiting In vitro Oligomerization of Cu/Zn-Superoxide Dismutase with a Mutation Causing Amyotrophic Lateral SclerosisSuppressing mutation-induced protein aggregation in mammalian cells by mutating residues significantly displaced upon the original mutationA revisited folding reporter for quantitative assay of protein misfolding and aggregation in mammalian cells.The legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron disease.Nuclear export of misfolded SOD1 mediated by a normally buried NES-like sequence reduces proteotoxicity in the nucleus.An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function.Induction of cell stress in neurons from transgenic mice expressing yellow fluorescent protein: implications for neurodegeneration research.50nm-scale localization of single unmodified, isotopically enriched, proteins in cells.An analysis of interactions between fluorescently-tagged mutant and wild-type SOD1 in intracellular inclusionsLarge-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase.N-terminal truncations of human bHLH transcription factor Twist1 leads to the formation of aggresomes.Polyanion binding accelerates the formation of stable and low-toxic aggregates of ALS-linked SOD1 mutant A4V.Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype.Structural and aggregation behavior of the human γD-crystallin mutant E107A, associated with congenital nuclear cataractSpinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells.Features of wild-type human SOD1 limit interactions with misfolded aggregates of mouse G86R Sod1.Marinesco-Sjögren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS.Implications of fALS Mutations on Sod1 Function and Oligomerization in Cell Models.Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models.In vivo genome editing improves motor function and extends survival in a mouse model of ALS.Genetic validation of a therapeutic target in a mouse model of ALS.A theoretical study on Zn binding loop mutants instigating destabilization and metal binding loss in human SOD1 protein.Antarctic marine ciliates under stress: superoxide dismutases from the psychrophilic Euplotes focardii are cold-active yet heat tolerant enzymes
P2860
Q21136374-EF425E88-0B83-4EDB-A55E-78E088123E6FQ28831086-B2ADE8EE-9779-47D1-BD59-A70EF9BEAD4CQ30278991-C1EF1E12-8782-4B68-97C6-96057FAF3437Q30416886-7A702752-16AE-4DB2-9964-A3D596137B42Q30435889-6245FEC1-F53F-4884-B9DF-2F8CFF17BA71Q33740006-D0BD755A-5A3F-4E64-87C8-B2FFBCC4BE25Q33795104-5C8FABE5-FA53-4234-9A56-EDD3A62ED152Q33847412-CE691BC1-8A1D-4359-9EBB-7C5F3767B061Q34595111-F1DD8451-72F3-43FD-A034-2ADD5E0A2048Q35082698-6F14FFD4-9391-4B34-9D75-7D88DB0FA46DQ37644005-C3B0C904-035E-4AFE-9BA5-B880F2C48F26Q38639533-FC10A32C-26F8-4E32-8B7B-48A73FAEF6FCQ38956652-41E94909-BBF6-4851-A2F6-8F10338680C1Q39217852-95577A2D-7F5A-4F33-B0DD-7AB94C984BBFQ39613123-E95B48E4-7449-4E3E-B962-A41DA2C6B2ECQ41634741-6D8AA999-03B3-42AA-AB32-1097DE486D6EQ41851111-693E36C1-6C6C-4809-8545-31106042571FQ42175672-C165C204-C844-4903-9CC3-74CD3CC1CD40Q46310468-1E23C83F-EA59-4D90-BD4D-429E48AA182EQ46537325-516680FD-6DE9-405F-A290-C0FED283660AQ47153099-3819F105-D618-4815-9A26-7D0443174065Q51064372-AB4F8A49-4B5F-4490-8915-A0B3FE5FFADDQ51107228-324D703E-0A11-4FAC-AF0D-033E3EB99FAFQ57041782-A9EAF482-263E-4D09-867F-90BA24D60D88
P2860
Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS)
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@ast
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@en
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@nl
type
label
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@ast
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@en
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@nl
prefLabel
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@ast
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@en
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@nl
P2093
P2860
P50
P3181
P1433
P1476
Modification of superoxide dis ...... rophic lateral sclerosis (ALS)
@en
P2093
James C Stevens
Jan van Minnen
Joanne E Martin
Linda Greensmith
Virginie Bros-Facer
William T Hendriks
P2860
P3181
P356
10.1371/JOURNAL.PONE.0009541
P407
P577
2010-03-08T00:00:00Z